{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:43:00Z","timestamp":1780472580176,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T00:00:00Z","timestamp":1432166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s10067-015-2971-5","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T05:19:07Z","timestamp":1432099147000},"page":"601-607","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients"],"prefix":"10.1007","volume":"35","author":[{"given":"Mihaela","family":"Sp\u00e2rchez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolae","family":"Miu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bolba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Iancu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeno","family":"Sp\u00e2rchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Rednic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,21]]},"reference":[{"key":"2971_CR1","first-page":"390","volume":"31","author":"RE Petty","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P et al (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390\u2013392","journal-title":"J Rheumatol"},{"key":"2971_CR2","author":"EH Dijkhuizen van","year":"2014","unstructured":"van Dijkhuizen EH, Wulffraat NM (2014) Early predictors of prognosis in juvenile idiopathic arthritis: a systematic literature review. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2014-205265","journal-title":"Ann Rheum Dis"},{"key":"2971_CR3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"GA Schellekens","year":"1998","unstructured":"Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101:273\u2013281","journal-title":"J Clin Invest"},{"key":"2971_CR4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","volume":"43","author":"GA Schellekens","year":"2000","unstructured":"Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155\u2013163","journal-title":"Arthritis Rheum"},{"key":"2971_CR5","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3899\/jrheum.131375","volume":"41","author":"J Payet","year":"2014","unstructured":"Payet J, Goulvestre C, Bial\u00e9 L et al (2014) Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients. J Rheumatol 41:2395\u20132402","journal-title":"J Rheumatol"},{"key":"2971_CR6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/ar658","volume":"5","author":"FA Gaalen van","year":"2003","unstructured":"van Gaalen FA, Linn-Rasker SP, van Venrooij WJ et al (2003) Autoantibodies predict progression to rheumatoid arthritis in undifferentiated arthritis: a prospective cohort study. Arthritis Res Ther 5:28","journal-title":"Arthritis Res Ther"},{"key":"2971_CR7","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar3237","volume":"13","author":"H Kokkonen","year":"2011","unstructured":"Kokkonen H, Mullazehi M, Berglin E, Hallmans G, Wadell G, R\u00f6nnelid J, Rantap\u00e4\u00e4-Dahlqvist S (2011) Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthritis Res Ther 13:R13","journal-title":"Arthritis Res Ther"},{"key":"2971_CR8","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1136\/ard.2003.019331","volume":"63","author":"O Kasapcopur","year":"2004","unstructured":"Kasapcopur O, Altun S, Aslan M et al (2004) Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 63:1687\u20131689","journal-title":"Ann Rheum Dis"},{"key":"2971_CR9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1590\/S0021-75572005000800014","volume":"81","author":"SH Machado","year":"2005","unstructured":"Machado SH, von M\u00fchlen CA, Brenol JC, Bisotto L, Xavier RM (2005) The prevalence of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. J Pediatr (Rio J) 81:491\u2013494","journal-title":"J Pediatr (Rio J)"},{"key":"2971_CR10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/ard.2007.084855","volume":"67","author":"RH Syed","year":"2008","unstructured":"Syed RH, Gilliam BE, Moore TL (2008) Prevalence and significance of isotypes of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 67:1049\u20131051","journal-title":"Ann Rheum Dis"},{"key":"2971_CR11","first-page":"825","volume":"30","author":"M Rossum van","year":"2003","unstructured":"van Rossum M, van Soesbergen R, de Kort S et al (2003) Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. J Rheumatol 30:825\u2013828","journal-title":"J Rheumatol"},{"key":"2971_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1546-0096-10-29","volume":"10","author":"A Tebo","year":"2012","unstructured":"Tebo A, Jaskwski T, Wayne Davis K et al (2012) Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Pediatr Rheumatol 10:29","journal-title":"Pediatr Rheumatol"},{"key":"2971_CR13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1546-0096-9-8","volume":"9","author":"BE Gilliam","year":"2011","unstructured":"Gilliam BE, Reed MR, Chauhan AK, Dehlendorf AB, Moore TL (2011) Evidence of fibrinogen as a target of citrullination in IgM rheumatoid factor-positive polyarticular juvenile idiopathic arthritis. Pediatr Rheumatol Online J 9:8","journal-title":"Pediatr Rheumatol Online J"},{"key":"2971_CR14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/08820130802438057","volume":"37","author":"HM Habib","year":"2008","unstructured":"Habib HM, Mosaad YM, Youssef HM (2008) Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Immunol Invest 37:849\u2013857","journal-title":"Immunol Invest"},{"key":"2971_CR15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/03009740510026634","volume":"34","author":"JS Kwok","year":"2005","unstructured":"Kwok JS, Hui KH, Lee TL et al (2005) Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population. Scand J Rheumatol 34:359\u2013366","journal-title":"Scand J Rheumatol"},{"key":"2971_CR16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/art.20773","volume":"52","author":"ED Ferucci","year":"2005","unstructured":"Ferucci ED, Majka DS, Parrish LA et al (2005) Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 52:239\u2013246","journal-title":"Arthritis Rheum"},{"key":"2971_CR17","first-page":"1829","volume":"31","author":"JM Low","year":"2004","unstructured":"Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL (2004) Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. J Rheumatol 31:1829\u20131833","journal-title":"J Rheumatol"},{"key":"2971_CR18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","volume":"369","author":"A Ravelli","year":"2007","unstructured":"Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369:767\u2013778","journal-title":"Lancet"},{"key":"2971_CR19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jbspin.2012.03.008","volume":"80","author":"A Omar","year":"2013","unstructured":"Omar A, Abo-Elyoun I, Hussein H, Nabih M, Atwa H, Gad S, Emad Y (2013) Anti-cyclic citrullinated peptide (anti-CCP) antibody in juvenile idiopathic arthritis (JIA): correlations with disease activity and severity of joint damage (a multicenter trial). Joint Bone Spine 80:38\u201343","journal-title":"Joint Bone Spine"},{"key":"2971_CR20","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1546-0096-12-22","volume":"12","author":"L Berntson","year":"2014","unstructured":"Berntson L, Nordal E, Fasth A et al (2014) Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA). Pediatr Rheumatol Online J 12:22","journal-title":"Pediatr Rheumatol Online J"},{"key":"2971_CR21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.24516","volume":"61","author":"A Consolaro","year":"2009","unstructured":"Consolaro A, Ruperto N, Bazso A et al (2009) Development and validation of a composite disease activity score for juvenile idiopathic arthritis. Arthritis Rheum 61:658\u2013666","journal-title":"Arthritis Rheum"},{"key":"2971_CR22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12098-010-0006-4","volume":"77","author":"R Gupta","year":"2010","unstructured":"Gupta R, Thabah MM, Vaidya B, Gupta S, Lodha R, Kabra SK (2010) Anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Indian J Pediatr 77:41\u201344","journal-title":"Indian J Pediatr"},{"key":"2971_CR23","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1136\/ard.2004.033571","volume":"64","author":"J R\u00f6nnelid","year":"2005","unstructured":"R\u00f6nnelid J, Wick MC, Lampa J, Lindblad S, Nordmark B, Klareskog L, van Vollenhoven RF (2005) Longitudinal analysis of citrullinated protein\/peptide antibodies (anti-CP) during 5\u00a0year follow up in early rheumatoid arthritis: anti-CP status predicts worse disease activity and greater radiological progression. Ann Rheum Dis 64:1744\u20131749","journal-title":"Ann Rheum Dis"},{"key":"2971_CR24","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1136\/ard.61.7.608","volume":"61","author":"T Avcin","year":"2002","unstructured":"Avcin T, Cimaz R, Falcini F et al (2002) Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 61:608\u2013611","journal-title":"Ann Rheum Dis"},{"key":"2971_CR25","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/rheumatology\/kei133","volume":"45","author":"P Dewint","year":"2006","unstructured":"Dewint P, Hoffman IE, Rogge S et al (2006) Effect of age on prevalence of anticitrullinated protein\/peptide antibodies in polyarticular juvenile idiopathic arthritis. Rheumatology (Oxford) 45:204\u2013208","journal-title":"Rheumatology (Oxford)"},{"key":"2971_CR26","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.semarthrit.2011.08.004","volume":"41","author":"S Breton","year":"2012","unstructured":"Breton S, Jousse-Joulin S, Finel E, Marhadour T, Colin D, de Parscau L, Devauchelle-Pensec V (2012) Imaging approaches for evaluating peripheral joint abnormalities in juvenile idiopathic arthritis. Semin Arthritis Rheum 41:698\u2013711","journal-title":"Semin Arthritis Rheum"},{"key":"2971_CR27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrrheum.2012.30","volume":"8","author":"S Magni-Manzoni","year":"2012","unstructured":"Magni-Manzoni S, Malattia C, Lanni S, Ravelli A (2012) Advances and challenges in imaging in juvenile idiopathic arthritis. Nat Rev Rheumatol 8:329\u2013336","journal-title":"Nat Rev Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2971-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-015-2971-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-015-2971-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:57:42Z","timestamp":1559120262000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-015-2971-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,21]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["2971"],"URL":"https:\/\/doi.org\/10.1007\/s10067-015-2971-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,21]]}}}